Stay updated with breaking news from Frank Karbe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Signifies the FDA’s recognition of the Company’s novel Cognitive Behavioral Therapy as a potential treatment for metabolic dysfunction-associated steatohepatitis Opens an accelerated path...
Better Therapeutics (Nasdaq:BTTX) announced today that the FDA granted breakthrough device designation for its MASH treatment.
Agreement is an important step towards securing broad coverage ...
Over a lifetime horizon AspyreRx plus standard of care was estimated to be superior to SoC alone providing more life years and improvements in quality of life at a lower cost Study suggests that...
Better Therapeutics, Inc. , a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announced it has submitted a request to the U.S. Food and Drug...